Combination weight-loss treatment for older adults with obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether adding an investigational drug (LUM-201) to a standard weight-loss medication (semaglutide) helps older adults with obesity lose more weight safely. It aims to see if the combination works better than semaglutide alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 60 and 84 years old.
- Your body mass index (BMI) is 30 or higher (a measure of body fat based on height and weight).
- You have tried to lose weight through diet before but were not successful.
- You do not have diabetes (type 1 or type 2).
- You have not taken weight-loss or diabetes medications in the past 3 to 6 months.
- You have not had weight-loss surgery and are not planning it during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a plant-based supplement (called 20E) to the weight-loss medication semaglutide can improve weight loss and muscle health. You would take the supplement as capsules alongside your regular semaglutide treatment.
This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.
This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.
This study tests a nasal spray containing semaglutide (a GLP-1 receptor agonist) to see if it helps adults who are overweight or obese lose weight. It may be an option if you have a BMI between 27 and 35 and have not used other weight loss medications recently.
This study tests whether a weight-loss medication (a GLP-1 agonist) can change how the brain works and help with long-term weight control. It involves brain scans and a closely monitored treatment plan.
This study tests a combination of two medications—a growth hormone-like drug and a semaglutide injection—to help adults with obesity lose weight. It aims to see if this combination is safe and effective for people who have not used these medications before.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.